Our long term goals are to identify and characterize proteins that may be regulating ion channel activity in Paramecium. Since a number of potential regulators have been cloned, our immediate task is simply to screen them using antisense technology. One class of regulators that we have cloned, the protein phosphatases, are important regulatory proteins that help coordinate other protein activities in the cell. My data indicates that a particular type of protein phosphatase, called protein phosphatase 1 (PP1), regulates the activity of one or both potassium channels present in Paramecium (the voltage dependent and the calcium dependent potassium channels). When these channels are not opened properly, the cell swims backwards for long periods of time (in the appropriate test solution). In my proposed research leave, I want to further characterize the role that PP1 plays in K+ channel regulation. Interestingly, there are two nearly identical genes that have both been affected by my antisense treatment. Thus one of my first goals is to determine if these genes are functionally redundant or have different roles to play in the cell.

The complete collection of PP1 isoforms that have been identified and cloned in Paramecium will be 'sorted' as to their role in the regulation of Paramecium electrophysiological processes using loss-of-function and gain-of-function approaches. It is essential to unequivocally determine which isoforms are involved so that subsequent experiments are precise and focused upon the appropriate targets.

1. Loss of function approach. Antisense techniques and one of two 'gene knockout' approaches will be utilized to provide an initial sorting of PP1 isoforms as to their role in the regulation of Paramecium swimming behavior.

2. Gain of function approach. This approach will verify and extend characterizations made in Part 1 above and if necessary, as a means to confirm negative results obtained in those experiments. It relies on the observation that okadaic acid (OA) is a PP1-specific inhibitor in Paramecium and does not inhibit Paramecium phosphoprotein phosphatase type 2A (PP2A). A molecular genetic approach will be used to generate okadaic acid resistant mutants to identify which isoforms need to be altered to confer resistance with regards to its effects upon swimming behavior and/or cell death.


Last updated July 18, 2001 Webmaster Dean Fraga.

 
Last updated Wednesday July 18, 2001 Webmaster Dean Fraga.